Search Results - "OOSTERWIJK, J. C"

Georg Schmorl on Trophoblasts in the Maternal Circulation by Lapaire, O, Holzgreve, W, Oosterwijk, J.C, Brinkhaus, R, Bianchi, D.W

“…Abstract Trafficking of cells between the fetus and its mother provides indirect clues to the underlying pathophysiology of pregnancy. Georg Schmorl first…”
Get full text

Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility by de Jong, M M, Nolte, I M, te Meerman, G J, van der Graaf, W T A, Oosterwijk, J C, Kleibeuker, J H, Schaapveld, M, de Vries, E G E

“…This review focuses on genes other than the high penetrance genes BRCA1 and BRCA2 that are involved in breast cancer susceptibility. The goal of this review is…”
Get full text

Randomized Trial of a Shared Decision-Making Intervention Consisting of Trade-Offs and Individualized Treatment Information for BRCA1/2 Mutation Carriers by VAN ROOSMALEN, M. S, STALMEIER, P. F. M, VERHOEF, L. C. G, HOEKSTRA-WEEBERS, J. E. H. M, OOSTERWIJK, J. C, HOOGERBRUGGE, N, MOOG, U, VAN DAAL, W. A. J

“…To evaluate a shared decision-making intervention (SDMI) for BRCA1/2 mutation carriers who have to make a choice between screening and prophylactic surgery for…”
Get full text

Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in the Netherlands: a cohort study by Hoogerwaard, EM, Bakker, E, Ippel, PF, Oosterwijk, JC, Majoor-Krakauer, DF, Leschot, NJ, Van Essen, AJ, Brunner, HG, van der Wouw, PA, Wilde, AAM, de Visser, M

“…Carriers of Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) may show muscle weakness or dilated cardiomyopathy. Studies focusing on…”
Get full text

The introduction of a choice to learn pre-symptomatic DNA test results for BRCA or Lynch syndrome either face-to-face or by letter by Voorwinden, JS, Jaspers, JPC, ter Beest, JG, Kievit, Y, Sijmons, RH, Oosterwijk, JC

“…Voorwinden JS, Jaspers JPC, ter Beest JG, Kievit Y, Sijmons RH, Oosterwijk JC. The introduction of a choice to learn pre‐symptomatic DNA test results for BRCA…”
Get full text

A clinical trial with chimeric monoclonal antibody WX-G250 and low dose interleukin-2 pulsing scheme for advanced renal cell carcinoma by Bleumer, I, Oosterwijk, E, Oosterwijk-Wakka, J C, Völler, M C W, Melchior, S, Warnaar, S O, Mala, C, Beck, J, Mulders, P F A

“…WX-G250 is a chimeric monoclonal antibody that binds to carbonic anhydrase IX(G250/MN), which is present on greater than 95% of RCCs of the clear cell subtype…”
Get more information

Perceiving cancer-risks and heredity-likelihood in genetic-counseling: how counselees recall and interpret BRCA 1/2-test results by Vos, J, Oosterwijk, JC, Gómez-García, E, Menko, FH, Jansen, AM, Stoel, RD, van Asperen, CJ, Tibben, A, Stiggelbout, AM

“…Vos J, Oosterwijk JC, Gómez‐García E, Menko FH, Jansen AM, Stoel RD, van Asperen CJ, Tibben A, Stiggelbout AM. Perceiving cancer‐risks and heredity‐likelihood…”
Get full text

Short-term surgical outcome and safety of risk reducing salpingo-oophorectomy in BRCA1/2 mutation carriers by Kenkhuis, M.J.A, de Bock, G.H, Oude Elferink, P, Arts, H.J.G, Oosterwijk, J.C, Jansen, L, Mourits, M.J.E

“…Abstract Objective Women with a BRCA1/2 mutation or members of a hereditary breast ovarian cancer family (HBOC) have an increased risk of developing ovarian…”
Get full text

Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer by KRIEGE, M, BREKELMANS, C. T. M, TILANUS-LINTHORST, M. M. A, SEYNAEVE, C, BARTELS, C. C. M, MEIJER, S, OOSTERWIJK, J. C, HOOGERBRUGGE, N, TOLLENAAR, R. A. E. M, DE KONING, H. J, RUTGERS, E. J. T, KLIJN, J. G. M, PETERSE, H, OBDEIJN, I. M, BOETES, C, ZONDERLAND, H. M, MULLER, S. H, KOK, T, MANOLIU, R. A, BESNARD, A. P. E

“…In the MRISC study, women with an inherited risk for breast cancer were screened by a 6-month clinical breast examination (CBE) and yearly MRI and mammography…”
Get full text

Impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer by van Roosmalen, Mariëlle S., Stalmeier, P.F.M., Verhoef, L.C.G., Hoekstra-Weebers, J.E.H.M., Oosterwijk, J.C., Hoogerbrugge, N., Moog, U., van Daal, W.A.J.

“…To evaluate the impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with cancer. Longitudinal cohort study…”
Get full text

Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250 by Steffens, M G, Boerman, O C, Oosterwijk-Wakka, J C, Oosterhof, G O, Witjes, J A, Koenders, E B, Oyen, W J, Buijs, W C, Debruyne, F M, Corstens, F H, Oosterwijk, E

“…Pharmacokinetics, biodistribution, immunogenicity, and imaging characteristics of iodine 131 (131I)-labeled chimeric monoclonal antibody (mAb) G250 (cG250)…”
Get more information

Randomised trial of a decision aid and its timing for women being tested for a BRCA1 2 mutation by van Roosmalen, M S, Stalmeier, P F M, Verhoef, L C G, Hoekstra-Weebers, J E H M, Oosterwijk, J C, Hoogerbrugge, N, Moog, U, van Daal, W A J

“…The aim of the study was to evaluate the impact of a decision aid (DA) and its timing in women being tested for a BRCA1/2 mutation. Women with and without a…”
Get full text

Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations by Leegte, B, van der Hout, A H, Deffenbaugh, A M, Bakker, M K, Mulder, I M, ten Berge, A, Leenders, E P, Wesseling, J, de Hullu, J, Hoogerbrugge, N, Ligtenberg, M J L, Ardern-Jones, A, Bancroft, E, Salmon, A, Barwell, J, Eeles, R, Oosterwijk, J C

Get full text

Refinement of the chromosome 16 locus for benign familial infantile convulsions by Callenbach, PMC, Van Den Boogerd, EH, De Coo, RFM, Ten Houten, R, Oosterwijk, JC, Hageman, G, Frants, RR, Brouwer, OF, Van Den Maagdenberg, AMJM

“…Benign familial infantile convulsions (BFIC) is an autosomal dominantly inherited partial epilepsy syndrome of early childhood with remission before the age of…”
Get full text

Hospital transfer after a breast cancer diagnosis: A population-based study in the Netherlands of the extent, predictive characteristics and its impact on time to treatment by Heeg, E., Schreuder, K., Spronk, P.E.R., Oosterwijk, J.C., Marang-van de Mheen, P.J., Siesling, S., Peeters, M.T.F.D. Vrancken

“…Patients may transfer of hospital for clinical reasons but this may delay time to treatment. The purpose of this study is to provide insight in the extent of…”
Get full text

Which screening strategy should be offered to women with BRCA1 or BRCA2 mutations? A simulation of comparative cost-effectiveness by de Bock, G H, Vermeulen, K M, Jansen, L, Oosterwijk, J C, Siesling, S, Dorrius, M D, Feenstra, T, Houssami, N, Greuter, M J W

“…Background: There is no consensus on the most effective strategy (mammography or magnetic resonance imaging (MRI)) for screening women with BRCA1 or BRCA2…”
Get full text

Rapid detection of BRCA1 mutations by the protein truncation test by Hogervorst, Frans B.L, Vasen, Hans F.A, van Ommen, Gert-Jan B, Cornelis, Renée S, Vliet, Margreethe van, Oosterwijk, Jan C, Olmer, Renske, Menko, Fred H, Cornelisse, Cees J, Meijers-Heijboer, Hanna, den Dunnen, Johan T, Devilee, Peter, Bakker, Bert, Klijn, Jan G.M, Bout, Mattie

“…More than 75% of the reported mutations in the hereditary breast and ovarian cancer gene, BRCA1, result in truncated proteins. We have used the protein…”
Get full text

Normal phenotype in two brothers with a full FMR1 mutation by Smeets, H J, Smits, A P, Verheij, C E, Theelen, J P, Willemsen, R, van de Burgt, I, Hoogeveen, A T, Oosterwijk, J C, Oostra, B A

“…The fragile X syndrome is associated with an expanding CGG repeat in the 5' untranslated region of the first exon of the FMR1 gene. Subsequent methylation of…”
Get more information

Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy by Hoogerwaard, E.M., van der Wouw, P.A., Wilde, A.A.M., Bakker, E., Ippel, P.F., Oosterwijk, J.C., Majoor-Krakauer, D.F., van Essen, A.J., Leschot, N.J., de Visser, M.

“…A cross-sectional study in a cohort of DNA proven carriers of Duchenne (DMD) and Becker (BMD) muscular dystrophy was undertaken with the following objectives:…”
Get full text

Psychological factors associated with the intention to choose for risk-reducing mastectomy in family cancer clinic attendees by van Driel, C.M.G, Oosterwijk, J.C, Meijers-Heijboer, E.J, van Asperen, C.J, Zeijlmans van Emmichoven, I.A, de Vries, J, Mourits, M.J.E, Henneman, L, Timmermans, D.R.M, de Bock, G.H

“…Abstract Objectives Women seeking counseling because of familial breast cancer occurrence face difficult decisions, such as whether and when to opt for…”
Get full text